The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immune toxicity in post autologous transplant patients treated with brentuximab vedotin in combination with immune checkpoint blockade.
 
Catherine S. Magid Diefenbach
Stock and Other Ownership Interests - Gilead Sciences
Consulting or Advisory Role - Bayer; Bristol-Myers Squibb; Genentech/Roche; Merck; Seagen
Research Funding - Bristol-Myers Squibb (Inst); Genentech (Inst); Incyte (Inst); LAM Therapeutics (Inst); Merck (Inst); Millennium (Inst); Seagen (Inst)
 
Fangxin Hong
No Relationships to Disclose
 
Richard F. Ambinder
No Relationships to Disclose
 
Jonathon Brett Cohen
Consulting or Advisory Role - Abbvie; Celgene; Infinity Pharmaceuticals; Millennium; Novartis; Pharmacyclics; Seagen
Research Funding - Bristol-Myers Squibb; Janssen; Novartis; Takeda
 
Kevin Andrew David
No Relationships to Disclose
 
Ranjana H. Advani
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Cell Medica; Genentech/Roche; Gilead Sciences; NanoString Technologies; Pharmacyclics; Seagen; Spectrum Pharmaceuticals; Sutter Medical Group
Research Funding - Agensys (Inst); Celgene (Inst); Forty Seven (Inst); Genentech/Roche (Inst); Infinity Pharmaceuticals (Inst); Janssen (Inst); Kura Oncology (Inst); Merck (Inst); Millennium (Inst); Pharmacyclics (Inst); Regeneron (Inst); Seagen (Inst)
 
Michael J. Robertson
No Relationships to Disclose
 
Timothy S Fenske
No Relationships to Disclose
 
Stefan K. Barta
Consulting or Advisory Role - Janssen Oncology
Research Funding - Celgene; Janssen Oncology; Merck; Seagen; Takeda
 
Neal Palmisano
No Relationships to Disclose
 
Jakub Svoboda
Consulting or Advisory Role - Seagen
Research Funding - Bristol-Myers Squibb; Celgene; Merck; Pharmacyclics; Seagen
Travel, Accommodations, Expenses - Merck
 
David S. Morgan
No Relationships to Disclose
 
Reem Karmali
No Relationships to Disclose
 
Brad Kahl
No Relationships to Disclose
 
Stephen M. Ansell
Honoraria - Research to Practice; WebMD
Research Funding - Affimed Therapeutics (Inst); Bristol-Myers Squibb (Inst); Pfizer (Inst); Regeneron (Inst); Seagen (Inst)